CD27 and melanoma: We also examined anti-CD27 with another direct tumor-targeting mAb, anti-gp75, in the B16F10 melanoma model (Figures 2F and 2G), where peritoneal metastases were assessed on day 13 after tumor inoculation (Otten et al., 2008).